Friday, October 11, 2019
Home »
» Medical News Today: Alzheimer's disease: Brain immune cells may offer new treatment target
Medical News Today: Alzheimer's disease: Brain immune cells may offer new treatment target
A new study attributes the link between tau protein clumping and brain damage in Alzheimer's disease to brain immune cells called microglia.
Related Posts:
With positive-test rate a record and new cases a near-record, Beshear says Kentucky is in a surge from Omicron; cities lead Demand for coronavirus tests was apparent Monday at a site in Lexington. (Photo by Ryan Hermens, Lexington Herald-Leader) By Melissa Patrick and Al Cross Kentucky Health News After two days of high case numbers and a… Read More
Kentucky has had a high death rate from Covid-19 since vaccines became widely available; relatively low vaccination rate is a reason New York Times graph, adapted by Kentucky Health News to highlight the state Centers for Disease Control graph, adapted by Ky. Health News Since vaccines for Covid-19 became widely available in April, Kentu… Read More
With few 5-to-11-year-olds vaccinated against Covid-19, public-health officials say kids will have to get sick to motivate parentsBy Sarah Baird, The Goldenrod Over the summer — during that fleeting window of time before the Delta variant hit when we believed Covid-19 might be evaporating into a gauzy nightmare of a memory — I interviewed a woman for a… Read More
Health reporter writes 'Five things about Omicron that I want my friends and family to know'Dan Diamond, a health reporter for The Washington Post, recently posted a Facebook thread about the Omicron variant of the coronavirus. It went viral, so he turned it into a story for the newspaper. He makes five points: For… Read More
With Omicron, more effective masks should be worn, experts say Chart from ShopMasks.com; click on it to elnarge. "With another coronavirus variant racing across the U.S., once again health authorities are urging people to mask up indoors. Yes, you’ve heard it all before," Maria … Read More
0 comments:
Post a Comment